Scholar Rock (SRRK) PT Raised to $33 at Wedbush, After Company Releases Clinical Trial Data

October 27, 2020 12:30 PM EDT
Get Alerts SRRK Hot Sheet
Price: $31.97 -0.53%

Rating Summary:
    7 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 26 | New: 41
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten raised the price target on Scholar Rock (NASDAQ: SRRK) to $33.00 (from $23.00) while maintaining a Outperform rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change